WOBURN, Mass. (March 7)—The shareholders of CardioTech International Inc. and Gish Biomedical Inc. have approved the merger of the two medical product firms. CardioTech will be the parent company. The deal provides the company with a leadership presence in the open heart surgery product market, said Michael Szycher, chairman and CEO of CardioTech. The transaction will give CardioTech access to Gish's clean room that's 40 times larger than its present operation and provides it with the resources necessary to expand its medical device manufacturing base, Szycher said
CardioTech, Gish shareholders approve merger
Rubber News wants to hear from its readers. If you want to express your opinion on a story or issue, email your letter to Editor Bruce Meyer at [email protected].